Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121651) titled 'Comparing the efficacy and safety of Funachizumab and Amgxitinib in the treatment of large artery vasculitis' on April 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Takayasu arteritis,TAK
Intervention:
Ivarmacitinib treatment group:ivarmacitinib
Vunakizumab treatment group:vunakizumab
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-04-01
Target Sample Size: Ivarmacitinib treatment group:60;Vunakizumab treatment group:60;Glucocorticoids therapy group:60;
Countries of Recruitment:
China
To kno...